A major thrust of the Vanderbilt Center in Molecular Toxicology involves the investigation of chemical and biological processes relating to the mode of action of genotoxic carcinogens. Genotoxins include environmental pollutants of industrial origin, pollutants of natural origin, substances that arise endogenously as products of oxidative metabolism, and drugs, foodstuffs and other substances to which man intentionally exposes himself. In order to understand the structural and mechanistic basis of DNA damage and mutagenesis, one must understand, 1) the types of adducts formed by the various mutagens and carcinogens and the other types of lesions such as those formed by oxidative metabolism, 2) the types of mutations produced by various polymerases and the mechanisms by which they arise, and 3) how the adducts alter the structure (i.e., conformation) of DNA and thereby degrade replication fidelity. At the same time, one needs to have an understanding of the extent and mechanism of recognition of the adducts (or the conformational alterations) by repair enzymes, p53 protein, transcription factors, and other proteins that interact with DNA in order to have a complete understanding of the biological properties of the adducts. Allied with these questions is the need to know the mechanisms of activation of carcinogens to form reactive species and the pathways by which the active species are detoxified. Some of these subjects are the focus of other research cores; close coordination exists between the activities of these other cores and those of the DNA Damage and Mutagenesis Core.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Center Core Grants (P30)
Project #
2P30ES000267-38
Application #
6725949
Study Section
Environmental Health Sciences Review Committee (EHS)
Project Start
2004-04-01
Project End
2009-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
38
Fiscal Year
2004
Total Cost
$23,654
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Wages, Phillip A; Kim, Hye-Young H; Korade, Zeljka et al. (2018) Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol. J Lipid Res 59:1916-1926
Neely, M Diana; Davison, Carrie Ann; Aschner, Michael et al. (2017) From the Cover: Manganese and Rotenone-Induced Oxidative Stress Signatures Differ in iPSC-Derived Human Dopamine Neurons. Toxicol Sci 159:366-379
Sha, Yan; Minko, Irina G; Malik, Chanchal K et al. (2017) Error-prone replication bypass of the imidazole ring-opened formamidopyrimidine deoxyguanosine adduct. Environ Mol Mutagen 58:182-189
Sugitani, Norie; Voehler, Markus W; Roh, Michelle S et al. (2017) Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates. J Biol Chem 292:16847-16857
Minko, Irina G; Rizzo, Carmelo J; Lloyd, R Stephen (2017) Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical ?-anomer. J Biol Chem 292:18790-18799
Rivara, Matthew B; Yeung, Catherine K; Robinson-Cohen, Cassianne et al. (2017) Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial. Am J Kidney Dis 69:389-399
Yan, H P; Roberts, L J; Davies, S S et al. (2017) Isolevuglandins as a gauge of lipid peroxidation in human tumors. Free Radic Biol Med 106:62-68
Shimada, Tsutomu; Takenaka, Shigeo; Murayama, Norie et al. (2016) Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13. Xenobiotica 46:211-24
Caito, Samuel W; Aschner, Michael (2016) NAD+ Supplementation Attenuates Methylmercury Dopaminergic and Mitochondrial Toxicity in Caenorhabditis Elegans. Toxicol Sci 151:139-49
Wakeman, Catherine A; Moore, Jessica L; Noto, Michael J et al. (2016) The innate immune protein calprotectin promotes Pseudomonas aeruginosa and Staphylococcus aureus interaction. Nat Commun 7:11951

Showing the most recent 10 out of 712 publications